Patent 12268428
Assignment history
Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.
Active provider: Google · gemini-2.5-flash
Assignment history
Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.
Inventors
- F. Barry Bays (Treace Medical Concepts Inc.)
- Robert D. Santrock (Treace Medical Concepts Inc.)
- Paul Dayton (Treace Medical Concepts Inc.)
- Daniel J. Hatch (Treace Medical Concepts Inc.)
- W. Bret Smith (Treace Medical Concepts Inc.)
- Carlos Eduardo Gil (Treace Medical Concepts Inc.)
- Sean F. Scanlan (Treace Medical Concepts Inc.)
- Joe William Ferguson (Treace Medical Concepts Inc.)
- John T. Treace (Treace Medical Concepts Inc.)
(All inventors appear to be associated with Treace Medical Concepts Inc., the original assignee, at the time of filing based on the patent's information).
Original assignee
The original assignee is Treace Medical Concepts Inc. They ship products embodying the claims, specifically surgical devices and methods for bunion correction, such as the Lapiplasty® 3D Bunion Correction™ System. Their primary line of business is the design, manufacture, and marketing of medical devices for foot and ankle pathologies. Treace Medical Concepts Inc. is currently an operating company.
Assignment timeline
The USPTO Patent Assignment Search was consulted. As of the current date, May 27, 2026, there are no recorded assignments for US Patent 12268428 beyond the original assignment to Treace Medical Concepts Inc. at the time of publication.
Timeline diagram
timeline
title Ownership of US 12268428
2024 : Filed by Treace Medical Concepts Inc
2025 : Issued
NPE / troll-pattern signals
- Shell-entity transfer — not present. The patent remains with the original operating company, Treace Medical Concepts Inc., which actively markets products.
- Known asserter in the chain — not present. The sole assignee is Treace Medical Concepts Inc., which is not identified as a known NPE.
- Repeat correspondent across the chain — not present. There is only one recorded assignment (the original grant), so no chain exists to show recurrence.
- Cascading transfers — not present. There is only one recorded assignment (the original grant).
- Pre-litigation transfer — not present. There are no recorded assignments that would precede litigation.
- Bankruptcy fire-sale — not present. Treace Medical Concepts Inc. is an active, operating company.
- Privateering — not present. No evidence of transfer to an NPE for assertion on behalf of an operating company.
- Defensive aggregator (anti-NPE) — not present. The patent is held by an operating company, not a defensive aggregator.
Verdict
Insufficient data. There are no recorded post-issuance assignments for US Patent 12268428. The patent is currently held by the original operating assignee, Treace Medical Concepts Inc., which manufactures and sells products related to the patented technology. Without any subsequent transfers, it is not possible to identify any NPE or troll patterns. The USPTO Assignment Center can be searched for verification at https://assignmentcenter.uspto.gov/.
Generated 5/27/2026, 6:49:10 PM